Package Leaflet: Information for the User
VEROLAX CHILDREN Rectal Solution
Glycerol
Read the package leaflet carefully because it contains important information for you.
This medication can be obtained without a prescription. Nevertheless, to obtain the best results, it should be used properly.
Contents of the Package Leaflet
Glycerol, the active ingredient of this medication, is a laxative that is administered rectally. The laxative effect is achieved by glycerol's ability to soften the stool, which, along with a mild local irritating action, stimulates intestinal movements.
It is indicated for the local symptomatic relief of transient and occasional constipation in children between 2 and 12 years old.
Be careful with VEROLAX
In case of the appearance of blood in stool, irritation, pain, or no improvement, you should interrupt treatment and consult a doctor.
Do not use this medication for more than 7 consecutive days, unless your doctor indicates otherwise.
This medication will only be used under strict medical control in patients with severe diseases, especially cardiovascular ones (related to the heart or blood vessels).
Use of other medications
Inform your doctor or pharmacist if you are using or have recently used other medications, including those obtained without a prescription.
Use in children
It should not be administered to children under 2 years old.
Pregnancy and breastfeeding
Consult your doctor or pharmacist before using any medication.
Driving and using machines
The use of this medication does not affect the ability to drive and/or use machines.
Follow the administration instructions of VEROLAX exactly as indicated by your doctor.
Consult your doctor or pharmacist if you have any doubts.
The normal dose is:
Children from 2 to 12 years old: 1 single-dose container per day.
This medication is administered rectally.
Instructions for the correct administration of the medication:
Each applicator is loaded with an excess of product, which remains in the applicator after use, so the amount released during application is the complete dose, and it is not necessary to empty it completely, which facilitates its handling. It should be discarded after use.
If you notice resistance during administration, you should interrupt it, as it may be harmful and damaging.
Do not use the medication for more than 7 consecutive days. If symptoms do not improve, you should suspend treatment and consult a doctor.
If you use more VEROLAX than you should
It is unlikely that intoxication will occur due to its use.
The abusive and prolonged use of this medication can lead to an irritable colon syndrome (symptoms or discomfort such as alternation of constipation and diarrhea, intestinal spasms, bloating, nausea, and gases).
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91.562.04.20, indicating the medication and the amount ingested.
Like all medications, VEROLAX can cause side effects, although not everyone will experience them.
During the period of use of VEROLAX rectal solution as a laxative, the following side effects have been observed, whose frequency has not been established with precision:
itching, pain, and irritation of the anus.
Very rarely, in allergic patients, hypersensitivity reactions to chamomile (e.g., contact dermatitis) have occurred. After internal use, these could be serious and could be: swelling of the face, lips, mouth, tongue, or throat that causes difficulty swallowing or breathing.
If you consider that any of the side effects you are suffering from is serious or if you notice any side effect not mentioned in this package leaflet, inform your doctor or pharmacist.
Keep out of the reach and sight of children.
No special storage conditions are required.
Do not use VEROLAX after the expiration date that appears on the container, after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown away in drains or trash. Ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.
Composition of VEROLAX
Appearance of the product and container contents
VEROLAX is presented as a light brown rectal solution.
The medication is packaged in a single-dose container in the form of a 2.5 ml bellows, equipped with a plastic cannula and a closing cap. These are packaged in a box containing 6 single-dose containers.
Marketing authorization holder
ANGELINI PHARMA ESPAÑA, S.L.
c/ Antonio Machado, 78-80
3rd floor, module A-Australia Building
08840 Viladecans, Barcelona (Spain)
Manufacturer
A.C.R.A.F. SpA
Via Vecchia del Pinocchio, 22
60131 Ancona (Italy)
This package leaflet was approved in May 2011.